Marsh Collaborates with IBM, ACORD, and ISN to Apply Blockchain Technology for First Commercial Proof of Insurance

Go back to Marsh Collaborates with IBM, ACORD, and ISN to Apply Blockchain Technology for First Commercial Proof of Insurance

Citi Remains Sidelined on IBM (IBM) Following 1Q

April 18, 2018 7:13 AM EDT

Citi reiterated a Neutral rating and $165.00 price target on IBM (NYSE: IBM) following the company's 1Q earnings report. IBM posted positive revenue growth of 5% year over year. IBM maintains its full year financial targets of at least $13.80 EPS (consensus at $13.83) and $12 billion in free... More